Patents by Inventor Alexis Valentin

Alexis Valentin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8604220
    Abstract: The subject of the invention is a novel molecule, Simalikalactone E, which can be extracted from the plant Quassia amara, and also the use thereof as a medicament, in particular in the prevention and treatment of malaria.
    Type: Grant
    Filed: June 17, 2010
    Date of Patent: December 10, 2013
    Assignee: Institut de Recherche Pour le Development
    Inventors: Valérie Jullian, Alexis Valentin, Eric Deharo, Geneviève Bourdy, Franciane Ho-A-Kwie, Nadia Cachet
  • Publication number: 20120149767
    Abstract: The invention relates to a device (1) for connecting/disconnecting a submersible connector (100) provided with a male portion (101) and a female portion (102), to a related connection/disconnection method, as well as to the various potential uses of said device. The device includes means (11, 12) for moving at least one of said male or female portions of the connector (100) between a connection position and a disconnection position and vice versa, and is characterized in that it further includes a system (16) for injecting a fluid (20) around the male (101) and female (102) portions of the connector (100) when the latter passes from the connection position thereof to the disconnection position thereof and vice versa, in order to insulate the same from the water surrounding the connector (100), the injection system (16) being located outside the connector (100).
    Type: Application
    Filed: June 17, 2010
    Publication date: June 14, 2012
    Applicant: INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT
    Inventors: Valérie Jullian, Alexis Valentin, Eric Deharo, Geneviève Bourdy, Franciane Ho-A-Kwie, Nadia Cachet
  • Patent number: 5290688
    Abstract: Method for the culture of Babesia divergens, characterized in that the Babesia strain is maintained under culture in a culture medium free from serous protein but containing lipoproteins and red blood corpuscles, and a method for preparing exoantigens and a vaccine containing these antigens.
    Type: Grant
    Filed: October 17, 1991
    Date of Patent: March 1, 1994
    Assignee: Rhone Merieux
    Inventors: Joseph Schrevel, Andre Gorenflot, Eric Precigout, Alain Marchand, Philippe Brasseur, Monique L'Hostis, Daniel Rigomier, Alexis Valentin, Emmanuel Vidor, Guy Bissuel